- Report
- May 2026
- 480 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 375 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 121 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 192 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 376 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 279 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 351 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 228 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 224 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 280 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 471 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 384 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- May 2026
- 566 Pages
Global
From €5210EUR$5,850USD£4,509GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,460GBP
- Report
- February 2026
- 250 Pages
Global
From €3999EUR$4,490USD£3,460GBP
- Clinical Trials
- April 2026
- 60 Pages
Global
From €1113EUR$1,250USD£963GBP
- Report
- April 2026
- 30 Pages
Global
From €2449EUR$2,750USD£2,119GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more